Talk to Alison

00 1 718 618 48 97

Search inside this page

Free Market Research Guides to Download

Biological Therapy Analysis & Statistics, July 2012 (p6)

You might be interested in: stem cell, cell therapy, cytokine, more »

» Purchase Premium Reports

151-180 of about 300 reports
Global Human Embryonic Stem Cell (hESC) Research Industry

Global Human Embryonic Stem Cell (hESC) Research Industry

  • $ 3 450
  • Industry report
  • July 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual ...

  • Industries : Biological Therapy
  • Countries : United States, World
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) ...

  • Industries : Biological Therapy
  • Countries : World, United States
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2012

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2012', provides ...

  • Industries : Biological Therapy
  • Countries : World
Alpha-Mannosidosis - Pipeline Review, H1 2012

Alpha-Mannosidosis - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Alpha-Mannosidosis - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Alpha-Mannosidosis - Pipeline Review, H1 2012', provides an overview of the Alpha-Mannosidosis therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Aplastic Anemia - Pipeline Review, H1 2012

Aplastic Anemia - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Aplastic Anemia - Pipeline Review, H1 2012', provides an overview of the Aplastic Anemia therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World
Adenovirus Infections - Pipeline Review, H1 2012

Adenovirus Infections - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Adenovirus Infections - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Adenovirus Infections - Pipeline Review, H1 2012', provides an overview of the Adenovirus Infections therapeutic pipeline. ...

  • Industries : Biological Therapy
  • Countries : World
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards Summary GBI Research's new report, ?Gene Therapy Market to ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy: Cytokine PharmaSciences, Inc.

Biological Therapy: Cytokine PharmaSciences, Inc.

  • $ 750
  • Company report
  • June 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Cytokine PharmaSciences, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline ...

  • Industries : Biological Therapy
  • Countries : United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

  • $ 250
  • Company report
  • June 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States, China
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications Summary GBI Research, the leading business intelligence ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cell Technologies: World Market Outlook 2012-2022

Stem Cell Technologies: World Market Outlook 2012-2022

  • $ 2 730
  • Industry report
  • May 2012
  • by Visiongain

Report Details Why the stem cells market will expand - discover its commercial potential What does the future hold for stem cells in medicine? Visiongain's report shows you potential revenues to 2022, ...

  • Industries : Biological Therapy
  • Countries : World
Competitor Analysis: Immunotherapy of Alzheimer`s Disease

Competitor Analysis: Immunotherapy of Alzheimer`s Disease

  • $ 516
  • Industry report
  • May 2012
  • by La Merie Publishing

Competitor Analysis: Immunotherapy of Alzheimer's Disease The Competitive Intelligence Report Immunotherapy of Alzheimer's Disease as of May 2012 provides a competitor analysis in the development pipeline ...

  • Industries : Biological Therapy
ProStrakan Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ProStrakan Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2012
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Global Stem Cell Research Industry

Global Stem Cell Research Industry

  • $ 4 500
  • Industry report
  • May 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Stem Cell Research in US$ Million. Annual estimates and forecasts are provided for the period 2008 through 2017. The report provides separate comprehensive ...

  • Industries : Biological Therapy
  • Countries : World, United States
Fibrocell Sciences, Inc. (Symbol:ILEIQ) SWOT Analysis, Strategy, Revenues and Profits

Fibrocell Sciences, Inc. (Symbol:ILEIQ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Global Growth Factors (Blood And Tissue) Industry

Global Growth Factors (Blood And Tissue) Industry

  • $ 4 500
  • Industry report
  • May 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Growth Factor Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, ...

  • Industries : Biological Therapy
  • Countries : World, United States, Japan, Europe
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2012
  • by Global Data

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Tissue Therapies Limited (TTL) is a publicly held Australian based biotechnology company. The company ...

  • Industries : Biological Therapy
  • Countries : Australia
Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, H1 2012

Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • April 2012
  • by Global Markets Direct

This report provides data on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
World Biological Therapy: Primary Systemic Amyloidosis - Pipeline Review, H1 2012

World Biological Therapy: Primary Systemic Amyloidosis - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • April 2012
  • by Global Markets Direct

This report provides data on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Biological Therapy
  • Countries : World
Global RNA Interference (RNAi) Industry

Global RNA Interference (RNAi) Industry

  • $ 4 800
  • Industry report
  • April 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis. The report ...

  • Industries : Biological Therapy
  • Countries : World
Human Stem Cell Banks in the US - Industry Market Research Report

Human Stem Cell Banks in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • April 2012
  • by Ibisworld

Human Stem Cell Banks Human stem cell banks collect, test, preserve and deliver stem cells from donors either for preparation of cell lines for use in research, or for future use through banking umbilical ...

  • Industries : Biological Therapy
  • Countries : United States
Global RNAi Market Analysis

Global RNAi Market Analysis

  • $ 1 200
  • Industry report
  • April 2012
  • by RNCOS

RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic applications ...

  • Industries : Biological Therapy
  • Countries : World
Global Gene Therapy Market Analysis

Global Gene Therapy Market Analysis

  • $ 1 200
  • Industry report
  • April 2012
  • by RNCOS

In the past few years, gene therapy has come a long way to become one of the most sought after methods to develop a treatment. Despite being at a nascent stage in terms of revenue generation, the gene ...

  • Industries : Biological Therapy
  • Countries : World
Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial company principally engaged in the development and distribution of anti-adhesion surgical products. ...

  • Industries : Biological Therapy
  • Countries : United States
Stem Cell Sciences Plc (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

Stem Cell Sciences Plc (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Medistem, Inc. (Symbol:MEDS) SWOT Analysis, Strategy, Revenues and Profits

Medistem, Inc. (Symbol:MEDS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Stem Cell Innovations, Inc. (Symbol:SCLL) SWOT Analysis, Strategy, Revenues and Profits

Stem Cell Innovations, Inc. (Symbol:SCLL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Chemokine Therapeutics Corp. (Symbol:CTI) SWOT Analysis, Strategy, Revenues and Profits

Chemokine Therapeutics Corp. (Symbol:CTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
Axiogenesis AG (Symbol:AI8) SWOT Analysis, Strategy, Revenues and Profits

Axiogenesis AG (Symbol:AI8) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Germany
Genitope Corporation (Symbol:GTOP) SWOT Analysis, Strategy, Revenues and Profits

Genitope Corporation (Symbol:GTOP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States

» Download Public Reports

About 1 100 reports
StemCells Inc. - Company Report for Year 2013

StemCells Inc. - Company Report for Year 2013

  • Company report
  • March 2013
  • 30 pages

... Biotechnology company. Gfap and nestin are proteins that are co-expressed by certain key cells found in the human central nervous system. Each patent claims a cell culture of undifferentiated gfap+ nestin+ cells ...


» Read our Company Profiles

36 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

Celgene Corp.

United States

StemCells Inc.

United States

Geron Corp.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.